Cyclacel stock: buy or sell?

CYCCP stock price: $6.47 -7.57% At close on May 13th, 2020

Updated on:
May 13th, 2020

0

Cyclacel Pharmaceuticals plunged -7.57% on May 13th to $6.47 after marking all time highs on April 20th. On May 7th CYCCP skyrocketed a dazzling 25.71%.

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases.

Should I buy Cyclacel stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Cyclacel stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Cyclacel stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for CYCCP stock for the last 30 days.

Cyclacel stock analysis

Daily outlook

Cyclacel Pharmaceuticals plunged -7.57% to $6.47 after topping to all time highs on April 20th.

On April 20th, CYCCP hit a new all time high, pushing higher than tops. Check different trading setups that use ATHs as triggers. After boosting a dazzling 25.71% on May 7th, Cyclacel Pharmaceuticals closed on May/13 at $6.47 and plunged a frightening -7.57%. On December CYCCP price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. From a daily outlook perspective, CYCCP is drawing an uptrend of rising tops and rising bottoms. Since its last top on Apr 20th at $8.07, price slid and bounced up back from $5.20. Breaking down under $5.20 would cancel the current uptrend and it might slide further to test lower supports. Note that $8.07 might act as a resistance line. Trading the long side, we should wait to a new breakout over $8.07 to find the next buy point.

CYCCP stock chart (daily)

Weekly outlook

After boosting an extraordinary 25.71% in a week early May, Cyclacel Pharmaceuticals closed this week at $6.47 and plummed a spooky -7.57%.

Not so far away is the last all-time high Cyclacel marked late April, but since then it dropped a 19.83%. Cyclacel stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Early May, SMA20w and SMA40w crossed up triggering a rise of 24.42%. Since mid January when CYCCP stock price broke up the SMA40w line, it gained $1.74 (36.79%).

CYCCP stock chart (weekly)

Cyclacel stock price history

Cyclacel IPO was on November 30th, 2005 at $1.02 per share1. Since then, CYCCP stock grew a 534.30%, with an average of 38.20% per year. If you had invested right after CYCCP's IPO a $1,000 in Cyclacel stock in 2005, it would worth $5,343.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Cyclacel stock historical price chart

CYCCP stock reached all-time highs on Apr 20th with a price of $8.07.

Cyclacel stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price prediction for Cyclacel Pharmaceuticals stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

CYCCP earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.38n/a
2017-Q2-n/a-0.5n/a
2017-Q3-n/a-0.91n/a
2017-Q4-n/an/an/a
2018-Q1-n/an/an/a
2018-Q2-n/an/an/a
2018-Q3-n/an/an/a
2018-Q4-n/an/an/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Cyclacel ownership

When you are planning to invest in a stock, it's worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Cyclacel Pharmaceuticals, 0.00% of all outstanding shares are owned by its staff.

In case of Cyclacel stock, 1.16% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CYCCP stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related companies:

CYCCP
Market cap$80.9 M
Total shares12.5 M
Float shares0.8 M
  - Institutional holdings (%)1.2%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

Cyclacel summary

Wednesday, May 13th, 2020
Open$7.43
Close$6.47
Day range$6.47 - $7.43
Previous close$7.00
Session gain-7.57%
Average true range$0.94
50d mov avg$5.05
100d mov avg$5.08
200d mov avg$4.64
Daily patternlb03a
Weekly pattern lt06a

Cyclacel performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. In the following table, we compare Cyclacel performance to :
Stock3m6m12m
CYCCPCyclacel Pharmace...47.38%23.95%36.79%

Cyclacel competitors

Unfortunately, we could not find any public company that could be defined as Cyclacel Pharmaceuticals competitor. This doesn't mean Cyclacel Pharmaceuticals does not have any competitor in the market, it's just we could not detected it.